1. Home
  2. Personal Injury Attorneys
  3. Article

Can Delayed Treatment of Newborn Jaundice Cause Lasting Injury?

7 min read
Can Delayed Treatment of Newborn Jaundice Cause Lasting Injury?

Delayed treatment of severe newborn jaundice can cause lasting neurological injury when bilirubin reaches dangerous levels and affects the brain. Yet jaundice is common, and a serious outcome alone does not establish that a healthcare provider acted negligently.

For families in Phoenix, Arizona, the central questions are whether clinicians recognized the infant’s risk, responded appropriately to bilirubin results, and provided timely treatment. A potential birth injury claim also requires evidence linking any failure in care to the child’s harm.

When Does Newborn Jaundice Become Dangerous?

Jaundice develops when bilirubin, a yellow pigment produced as red blood cells break down, accumulates in the bloodstream. Newborns produce bilirubin relatively quickly, while their developing livers may eliminate it less efficiently. Mild elevations often resolve without permanent consequences.

Severe hyperbilirubinemia is different. Excessive unconjugated bilirubin can enter vulnerable brain tissue and cause bilirubin induced neurological dysfunction. In the most serious cases, a child may develop lasting impairment associated with kernicterus.

The American Academy of Pediatrics (AAP) provides recommendations for managing hyperbilirubinemia in newborns at least 35 weeks’ gestation. Treatment thresholds account for the infant’s age in hours, gestational age, bilirubin concentration, and factors increasing the risk of neurological toxicity. No single result dictates the same treatment for every child.

How Can Kernicterus Affect Development?

Kernicterus is permanent neurological injury associated with bilirubin toxicity. Potential consequences include movement disorders, hearing impairment, and certain forms of cerebral palsy. Individual outcomes vary with the nature and extent of the injury.

Importantly, not every infant with high bilirubin develops kernicterus, and not every neurological difficulty following birth results from jaundice. Determining what caused a particular child’s condition requires evaluation of the medical evidence, not an assumption based on diagnosis alone.

Why Does the Clinical Timeline Matter?

Bilirubin concentrations can increase over the first days of life, including after a newborn leaves the hospital. Whether a delay was unreasonable depends on the information available to the healthcare team at each point, rather than simply the moment jaundice became visible.

Initial Assessment and Testing

Jaundice appearing in the first 24 hours may signal a greater risk of significant hyperbilirubinemia and generally warrants prompt evaluation. Certain conditions, including hemolysis, can increase bilirubin production. Clinicians consider laboratory results, the infant’s condition, and relevant risk factors when deciding on further assessment.

The AAP recommends predischarge bilirubin measurement for infants covered by its guideline. The relationship between that result and the relevant treatment threshold helps determine whether further monitoring or intervention is appropriate.

A concerning result does not automatically establish malpractice. Its legal significance depends on how the result was interpreted, what follow-up was indicated, and whether the response met the applicable standard of care.

Treatment Decisions and Phototherapy

Phototherapy uses light to convert bilirubin into forms the body can eliminate more readily. When clinically indicated, it can lower bilirubin concentrations and reduce the risk of worsening disease. Some particularly severe cases may require escalation of care, potentially including exchange transfusion.

Consider a hypothetical newborn whose bilirubin level reaches the applicable phototherapy threshold. Treatment is not initiated within a clinically reasonable period, and the child later develops neurological injury. That sequence could raise questions about the timing of care, but it would not independently prove negligence.

An evaluation must address whether treatment was indicated when the result became available, whether clinicians had access to that information, and whether earlier treatment probably would have prevented or reduced the injury.

Another important distinction concerns a change in the infant’s condition after a reassuring earlier assessment. A result that was reasonable to monitor at one hour may require intervention later as bilirubin increases. Evaluating care therefore involves the sequence of findings rather than treating a prior reassuring assessment as conclusive. Likewise, families may hear different descriptions of jaundice severity from different clinicians. Those descriptions must be considered alongside actual measurements and clinical context. In a legal review, the important issue is whether relevant information was available and appropriately and promptly acted upon, not whether every note used identical language.

Can Discharge and Follow-Up Decisions Contribute to Harm?

Because bilirubin may peak after discharge, a newborn’s apparent stability at one examination is not the entire basis for appropriate discharge planning. Providers consider predischarge measurements, the infant’s risk factors, and the timing of further assessment.

Under the AAP’s approach, the difference between the measured bilirubin level and the phototherapy threshold helps inform follow-up timing. Infants closer to that threshold may need earlier reassessment than those whose concentrations are substantially lower.

If severe jaundice develops after discharge, a later review may examine whether the recommended follow-up matched the clinical findings known at the time. Still, deterioration after discharge does not itself establish that discharge planning was improper.

When Might a Delay Constitute Medical Negligence?

Arizona Revised Statutes § 12-563 requires proof that a healthcare provider failed to exercise the degree of care expected under similar circumstances and that the failure was a proximate cause of the injury. The question is not simply whether a child was harmed, but whether a legally significant departure from appropriate care caused that harm.

A Birth injury lawyer evaluating a potential Phoenix claim may consider the chronological relationship among bilirubin results, clinical assessments, treatment decisions, and subsequent neurological findings. The applicable medical guidance at the time of treatment matters; later recommendations should not automatically be imposed on care delivered earlier.

Standard of Care and Causation Are Different Questions

First, the evaluation must address whether reasonable healthcare providers under comparable circumstances would have assessed, monitored, treated, or referred the infant differently.

Second, it must address causation. Even where a delay occurred, medical evidence must support the conclusion that the delay caused or worsened the child’s injury. Some newborns face elevated risks because of gestational age, hemolysis, or other medical conditions. Those risks neither establish negligence nor automatically excuse a preventable treatment failure.

Medical reviewers may consider whether a different response probably would have changed the infant’s neurological outcome. This analysis is particularly important when disease progression or underlying conditions complicate the timeline.

What Evidence Helps Explain the Course of Care?

The relevant records may include bilirubin measurements, the infant’s age at testing, nursing and physician assessments, treatment orders, phototherapy documentation, discharge summaries, and follow-up recommendations. Together, these materials can help clarify what clinicians knew and when.

Bilirubin and Treatment Records

Repeated bilirubin measurements may show how quickly levels rose and whether treatment thresholds were approached or crossed. Records can also indicate when treatment was ordered and administered. Differences between those times need context; a gap is not automatically proof that care was unreasonable.

Clinical circumstances may affect the interpretation of every measurement. The importance of a result depends on the infant’s age, gestational age, relevant risk factors, and other findings.

Neurological Findings and Long-Term Effects

If a child later develops neurological impairment, medical evaluations may clarify the diagnosis and its consequences. Hearing assessments, developmental evaluations, neurological examinations, and relevant imaging can help describe functional limitations, although no single finding necessarily establishes the cause.

The child may require continuing treatment, rehabilitation, assistive equipment, or educational support. In a legally supported claim, those future needs can be relevant to damages. The nature of the support must reflect the child’s documented condition rather than assumptions about what every child with jaundice will require.

Why Are These Claims Evaluated Individually?

Two newborns with similar bilirubin concentrations may face different risks or require different clinical responses. Likewise, two children with neurological impairment may have different medical histories and causes of injury.

A birth injury attorney assessing severe jaundice considers whether the evidence supports both a failure in care and a causal connection to the claimed harm. A birth injury lawsuit cannot rest solely on the fact that phototherapy began later than a family expected or that the eventual outcome was serious.

The legal analysis also distinguishes screening concerns from treatment delays and follow-up failures. Each involves different decisions, responsibilities, and medical facts. An unfavorable result can prompt important questions without answering whether a healthcare provider is legally liable.

Understanding Accountability After Severe Jaundice

Severe hyperbilirubinemia can lead to permanent neurological harm, but its occurrence does not automatically mean that medical care was negligent. The decisive issues include whether the healthcare team appropriately assessed risk, interpreted results, initiated indicated treatment, and arranged suitable follow-up.

When a preventable delay may have contributed to kernicterus or another bilirubin related injury, a professional medical and legal evaluation can help families understand whether Arizona malpractice standards support a claim. That assessment should examine the complete clinical timeline and the child’s actual needs, rather than relying on an isolated laboratory result.

About Snyder & Wenner, P.C.

Established in 1983, Snyder & Wenner, P.C. represents Arizona families in serious medical malpractice and birth injury matters, with offices in Phoenix, Scottsdale, and Tucson. Their attorneys include firm partners Howard M. Snyder, David A. Wenner, and Brian A. Snyder. Families seeking information about potential representation can call the Phoenix office at (602) 224-0006 or Find their Phoenix office on Google Maps.

More in Personal Injury Attorneys

View the category